Page last updated: 2024-09-04

lonafarnib and Cirrhosis

lonafarnib has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Caviglia, GP; Ibadullaeva, N; Ismoilov, U; Joldasova, E; Khikmatullaeva, A; Khodjaeva, M; Musabaev, E; Rizzetto, M; Said, S; Shahnoza, A	1

Other Studies

1 other study(ies) available for lonafarnib and Cirrhosis

Article	Year
Hepatitis D virus in Uzbekistan. The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:3 Topics: Adult; Chronic Disease; Female; Fibrosis; Global Burden of Disease; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Incidence; Interferon-alpha; Lipopeptides; Liver Diseases; Male; Middle Aged; Piperidines; Prevalence; Pyridines; Risk Factors; Superinfection; Uzbekistan	2020

Article

Year

Hepatitis D virus in Uzbekistan.

The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:3

Topics: Adult; Chronic Disease; Female; Fibrosis; Global Burden of Disease; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Incidence; Interferon-alpha; Lipopeptides; Liver Diseases; Male; Middle Aged; Piperidines; Prevalence; Pyridines; Risk Factors; Superinfection; Uzbekistan

2020